Retinal ganglion cell (RGC) degeneration is extremely hard to repair or regenerate and is often coupled with mitochondrial dysfunction. Mesenchymal stem cells (MSCs)-based treatment has been demonstrated beneficial for RGC against degeneration. However, underlying mechanisms of MSC-provided RGC protection are largely unknown other than neuropectective paracrine actions. In this study, we sought to investigate whether mitochondrial donation can preserve RGC functions, in a mitochondrial Ndufs4 deficient mouse model of RGC degeneration. The results revealed intravitreal transplanted by induced pluripotent stem cell derived -MSCs (iPSC-MSC) could donate their mitochondria through crossing inner limited membrane to host RGCs. Furthermore, the donated mitochondria effectively protected against RGC death and largely preserved retinal function in Ndufs4-KO mice. Importantly, the protective effects of mitochondrial donation from MSCs were associated with management of pro-inflammatory cytokines. Our data identified a novel role of MSCs-mitochondrial donation in protection of RGC from degeneration, and highlight a viable therapeutic strategy by manipulating stem cell mitochondrial donation for the treatment of retina degeneration in future.
Introduction
Exogenous administration of mesenchymal stem cells (MSC) is protective in retinal degeneration, including glaucoma and Leber's hereditary optic neuropathy (LHON) (Inoue et al., 2007; Johnson et al., 2010a; Ng et al., 2014; Yu-Wai-Man et al., 2014) Gregory-Evans, 2010; Kicic et al., 2003; Phinney and Prockop, 2007; Ratajczak et al., 2004; Tomita et al., 2006) . Conventionally, MSC transplantation has long been thought to provide neuroprotective paracrine factors for retinal protection (Johnson et al., 2010a; Manuguerra-Gagne et al., 2013; Mead et al., 2015; Torrente and Polli, 2008) . Nonetheless, use of paracrine factor-based therapies has often produced inconsistent and even conflicting results in treatment studies (Inoue et al., 2007; Li et al., 2009 ). Thus, the paracrine effects of MSCs do not fully explain the mechanisms of MSC-modulated retinal protection.
MSCs are capable of transferring their mitochondria to pheochromocytoma PC12 cells, lung airway cells, corneal cells and cardiomyocytes, and improve mitochondrial bioenergetics (Islam et al., 2012; Jiang et al., 2016; Plotnikov et al., 2008; Rustom et al., 2004; Spees et al., 2006) . Recently it has been reported that MSCs can transfer mitochondria to astrocytes and restore the bioenergetics of the recipient cells and stimulate their proliferation (Babenko et al., 2018) . We considered the alternative possibility that the protective effect of MSCs involves mitochondrial transfer to neural cells in the retina such as retinal ganglion cells (RGC) . RGCs are responsible for propagating signals derived from visual stimuli in the photoreceptor cells in the eye to the lateral geniculate body/superior colliculus in the brain, through their long axons (London et al., 2013; Rodieck, 1965; Zhang et al., 2016) . Due to the natural complexity of RGCs in neuronal development, axon guidance, and complex synaptic connections, they are almost impossible to repair or replace once damaged (Aguayo et al., 1990; Almasieh et al., 2012; Goldberg et al., 2002; Hilla et al., 2017; Levkovitch-Verbin et al., 2001) . Another challenge is that it is thought unlikely that intravitreal injected cells can pass through the inner limiting membrane of the retina (Quigley and Iglesia, 2004) . We have previously reported that compared with adult bone marrow-derived mesenchymal stem cells, induced pluripotent stem cell-derived mesenchymal stem cells (iPSC-MSCs) can more efficiently donate functional mitochondria to rejuvenate injured heart, lung and corneal tissues (Jiang et al., 2016; Li et al., 2018; Zhang et al., 2016) . Hence, it is of great import to investigate whether iPSC-MSCs can transfer mitochondria to
RGCs and whether such a transfer is therapeutic.
We studied these issues using a Ndufs4 knockout (KO) mouse model with defined mitochondrial complex I deficiency (Yu et al., 2015) . We reported an unexpected acute effect of intravitreal iPSC-MSCs transplantation on the rescue of RGCs in this model through direct mitochondrial transfer. Importantly, the protective effects of mitochondrial donation from MSCs were associated with management of pro-inflammatory cytokines. Our findings challenge the current belief that protection of RGCs by MSCs is merely through their paracrine effect and suggest that the functional mitochondrion of MSCs can pass through the inner limiting membrane and halt mitochondrial damage-provoked RGC death, enabling us to better understand stem cell therapy in retinal mitochondrial disorders and to develop a novel strategy for retinal repair by manipulating intercellular mitochondrial transfer.
Results

Retinal ganglion cell degeneration in Ndufs4 deficient mice
To evaluate the onset and development of RGC damage and so determine the optimal period for therapeutic intervention, we first evaluated the changes to RGCs over time in Ndufs4 KO mice. Given a life span of up to 9 weeks for KO mice (Irwin et al., 2013) , retinal pathological changes were examined between week 3 and week 7. To determine the loss of RGCs, counting cells that were Brn3a positive, an RGC marker, was performed on mounted whole retinas of KO and WT mice. The number of Brn3a positive RGCs in KO mice retinas declined significantly at week 6 and week 7 when compared to WT ( Figure 1A ). No significant changes were observed in ERG when Ndufs4 KO mice were compared with WT mice at week 3 ( Figure 1B ). Nonetheless compared with WT mice, significant decreases in b-wave and PhNR amplitude were observed at week 4 in KO mice (p<0.05 WT vs. KO). Morphometric analysis of the retinal section revealed that the thickness of the inner plexiform layer (IPL) of both the central and peripheral retina had declined significantly in KO mice by postnatal week 7 ( Figure 1C ). In addition, since high levels of glial fibrillary acidic protein (GFAP) has been associated with Müller cell activation accompanies with RGC loss (Kurihara et al., 2006) , we examined GFAP expression at different times in KO mice.
At week 3, GFAP positive cells were observed only in Müller end-feet and astrocytes in the nerve fiber layer of retinas in both WT and KO mice ( Figure EV1 ). At week 4, the expression of GFAP in retinas of KO mice reached into the inner plexiform layer (IPL). By week 7, an increasing fluorescent signal of GFAP was observed to axial extent throughout the retina of KO mice ( Figure EV1 ).
Taken together, a time course-based ERG analysis revealed dysfunction of retinal ganglion cells started at week 4, RGC density decrease in the flat-mounted retina was detectable at week 6, and significant reduced retinal thickness in morphometric analysis at week 7. Abnormal activation of Müller cells was detectable by week 4 and extensively distributed throughout the whole retina by week 7. These data support the hypothesis that mitochondrial complex I dysfunction in the retina results in RGC functional loss and death, similar to the phenotype of Leber's hereditary Optic Neuropathy. On or before week 3 at the very early phase of RGC damage may be a treatment window to prevent RGC loss and functional degeneration. For this reason, we performed intravitreal injection at week 3 and examined mice 96 hours, 1 week and 4 weeks post iPSC-MSC transplantation ( Figure EV2 ).
Detection of mitochondrial transfer from iPSC-MSCs to retina
To determine whether intravitreal delivery of iPSC-MSCs could transfer mitochondria to retinal cells and pass through the inner limiting membrane in vivo, mitochondria of iPSC-MSCs were genetically labeled with LV-Mito-GFP prior to intravitreal injection (Zhang et al., 2016) . In the whole mount retina, GFP positive mitochondria from iPSC-MSCs were detected within TUBB3 positive mouse RGCs (Figure 2A ).
Z-stake reconstructed images and video of the retina ( Figure 2B -C and Movie EV1) clearly showed that most mitochondria of iPSC-MSCs were translocated within the ganglion cell layer (GCL). In addition, only a few mitochondria were detected within the inner nuclear layer (INL) and inner plexiform layer (IPL) (indicated by triangular arrowheads) ( Figure 2B -C). This indicates that cells in the GCL directly took up mitochondria from iPSC-MSCs. We also detected the transferred mitochondria in primary isolated RGCs during co-culture with MSCs ex vivo ( Figure EV3 ).
To examine transfer efficiency of mitochondria, mitochondria within retina were analyzed at 96 h, 1 week and 4 weeks post iPSC-MSC administration by immunostaining assay against anti-GFP (488), TUBB3(594), and Hoechst (405) staining. Mitochondrial transfer from iPSC-MSCs to the retina was evident as early as 96 hours after treatment and GFP intensity was significantly increased 1 week post iPSC-MSC administration ( Figure 2D ). By 4 weeks, no MSC left in the vitreous chamber on top of the inner limiting membrane. However, GFP positive mitochondria were still detectable within the RGL ( Figure 2D ). To exclude non-specificity of immunostaining against GFP, another set of antibodies was used including Brn3a (488), anti-human mitochondria (anti-Mito, 594) and DAPI (405) ( Figure EV4 ).
Similarly, human mitochondria were detected and were most abundant 1-week post iPSC-MSC administration, compared with 96 hours and 4 weeks ( Figure 2D & Figure   EV4 ).
Penetration of mitochondria but not MSCs into retina
To determine whether injected iPSC-MSCs could penetrate the inner limiting membrane and migrate to the RGC layer or just transfer healthy mitochondria into retinal cells, mice retinas were isolated from the underlying RPE and snap frozen for PCR. Vitreous body was carefully separated from retina. Four pairs of primers designed for human specific nuclear DNA(H-nDNA), human specific mitochondrial DNA (H-mDNA), mice specific nuclear DNA(M-nDNA) and specific mitochondrial DNA (M-mDNA) were used to detect DNA information within the retinal tissue (Zhang et al., 2016) . In all the iPSC-MSC injected mice eyes, human mitochondrial DNA was detected within mice retinas but no human nuclear DNA was detected at any of the analyzed timepoints ( Figure 3A) . To exclude the possibility of contamination of human cells in mice retina in PCR assay, we performed immunostaining against human-nuclear antibody (HNA) to detect human-specific antibody in retinal sections. We found positive HNA (Human nuclear marker) only in the vitreous cavity but not any layers of the retina ( Figure 3B -C). These results indicate that mitochondrial transfer from iPSC-MSCs to the retina occurred as early as 96hrs following iPSC-MSC injection and remained within the retina 4 weeks after administration. Of note, after intravitreal injection, only mitochondria of iPSC-MSCs could be transferred into the mice retina while no iPSC-MSCs could pass through inner limiting member and integrated into the retina of mice.
To clarify how iPSC-MSCs donate mitochondria to RGCs and penetrate the inner limiting memberane, we tracked iPSC-MSCs located in the eyeball. We established that iPSC-MSCs could be detected on the surface of the vitreoretinal membrane 96 hours and 1 week after injection ( Figure 3D ). These intravitreal injected iPSC-MSCs were tightly attached on the surface of the vitreoretinal membrane and formed almost a single layer ( Figure 3Di ). Z-stack images revealed that the layer of RGCs was 2-3 μM beneath the iPSC-MSCs attached on the inner limiting membrane ( Figure 3Dii ). It is possible that MSC-formed TNTs with diameter of 30-200 nm and length of 30 μM could penetrate the barrier and connect with RGCs for mitochondria transfer ( Figure   3Diii ). Another possibility is that the astrocyte and the end foot of Muller cell in the limiting membrane transported mitochondria into the RGC layer. Although mitochondria from iPSC-MSCs remained detectable until 4 weeks after injection, we failed to detect any iPSC-MSCs on the surface of the vitreoretinal membrane ( Figure   3D ). This concurs with previous reports of short-term survival of iPSC-MSCs following intravitreal transplantation (Hill et al., 2009; Labrador Velandia et al., 2018) .
Prevention of RGC loss with iPSC-MSCs treatment in Ndufs4 deficient mice
To determine whether iPSC-MSC administration prevents RGC loss in an Ndufs4 mouse model, we performed intravitreal injection of iPSC-MSCs into 3 week old Ndufs4 KO mice. Age and sex matched KO mice were divided into three groups randomly and subjected to one of the following: iPSC-MSC treatment (KO+MSC), vehicle treatment (KO+PBS), iPSC-MSC pre-treated with rotenone to induce dysfunctional mitochondria (KO+MSC(R)). WT littermate mice with vehicle administration served as controls (WT+PBS). After 1 week of treatment (4 week old mice), number of RGCs did not differ significantly between WT+PBS, KO+PBS and KO+MSC group, confirming that RGC loss could not be detected until week 6 ( Figure 1A) . Surprisingly, compared with the KO+MSCs group, RGCs in the KO+MSC(R) group were significantly reduced ( Figure 4A , p<0.05) even less than the control group. These results provide an important warning that transplantation of mitochondrial dysfunctional MSCs no longer has the capacity for RGC protection and are also harmful to RGC homeostasis, leading to RGC loss. By 4 weeks after iPSC-MSCs injection (mice at 7 weeks of age), whole retina analysis revealed that Ndufs4 KO mice with vehicle administration (PBS group) presented a significant reduction in RGCs compared with WT mice with PBS treatment ( Figure 4A ,p<0.001).
In contrast, iPSC-MSC administration significantly prevented RGC loss compared with vehicle treatment in Ndufs4 KO mice ( Figure 4A , p<0.05). Of note, compared with their WT counterparts, MSC(R) treatment failed to protect RGCs from death in KO mice and only around 1/2 of all RGCs remained by 4 weeks post transplantation.
Administration of iPSC-MSCs prevents functional decline of RGCs in an Ndufs4 mouse model
In Ndufs4 knockout mice, ERG measurement showed significant functional impairment of the retina prior to the development of neurodegeneration with detectable cell loss ( Figure 1B ). We therefore determined whether iPSC-MSC-based treatment could improve the electrical response of the mouse retina with defective mitochondria. Waveforms derived from photoreceptors (a-wave), the inner retina (b-wave) and RGCs (PhNR) were recorded.
At 1 week post treatment, the KO-MSC and KO-PBS group showed no significant differences in the changes to a-wave and b-wave amplitudes compared with age-matched WT mice (WT-PBS) ( Figure 4B ). Nonetheless compared with the KO-PBS group, KO-MSC mice showed significantly increased a-wave amplitudes ( Figure 4B ). Moreover, the PhNR amplitude in KO-PBS mice showed a significant decrease compared with that of WT-PBS control mice ( Figure 4B 
Müller cell activation and inflammatory response in whole retina of
Ndufs4-diffecient mice
It has been reported that glial fibrillary acidic protein (GFAP) is normally expressed in astrocytes in WT mice. In response to retinal injury, GFAP gene transcription is strongly activated in the müller cell. To evaluate müller cell activation following iPSC-MSC based therapy in complex I defect mice immunohistochemistry of GFAP was performed. GFAP positive cells were limited in Müller cell end-feet and astrocytes in the nerve fiber layer and ganglion cell layer (GCL) of the retina in WT control mice ( Figure 5A ). By week 7, the GFAP positive signal in KO mice had shown an axial extent throughout the retina with an increased intensity ( Figure 5A-B ).
As shown in figure 5A Results of Cytokine protein arrays and hierarchical clustering analysis of differential protein expression unveiled that compared with week4 WT mice (W4WT+PBS), KO mice (W4KO+PBS) are biased to an inflammatory status as evidenced by remarkably increased pro-inflammatory cytokines (i.e. CD30L, IL-5, TNFα, IFNg etc.) but decreased anti-inflammatory cytokines and cell survival factors (i.e. IL-10, ICAM1etc.)( Figure EV5 & Table EV1 ). Notably, many of these prominently increased cytokines such as IL-17, IL-1b TNFα, and CD30L (Abdalla et al., 2004; Bonizzi and Karin, 2004; Franchi et al., 2006; Infante-Duarte et al., 2000; Jovanovic et al., 1998; Yue et al., 2005) are associated with activation of NF-κB signaling pathway, a master signaling pathway in the regulation of inflammation.
Importantly, one week post iPSC-MSC treatment, the enhanced pro-inflammatory cytokines had remarkably declined in the retina of KO mice (W4KO+MSC).
Nonetheless rotenone-treated iPSC-MSCs (W4KO+MSC(R)) lost protective ability when compared with the W4KO-MSC group. Of note, pro-inflammatory cytokines of W4KO-MSC(R) mice were much higher than those of W4KO-PBS mice, indicating that MSCs with dysfunctional mitochondria have lost anti-inflammatory properties instead are harmful to the retina ( Figure EV5 & Table EV1 ).
We A total of 22 proteins that display 1.50 or above folds of difference in at least one of these comparisons were identified. By hierarchical clustering analysis on expression of these differential proteins using Cluster 3.0, we detected three clusters of cytokines and treatment groups with similar profile ( Figure 6 ). As shown at Figure 
Discussion
In this study, we have demonstrated that retinal ganglion cells (RGCs) display functional defects and eventually death in a Ndufs4 knockout mouse model; , 2005) . High production of cytokines such as TNF α and activation of NF-κB signaling in KO mice might be the trigger for mitochondrial transfer. We found that
Rotenone pretreated MSC lost their protective effect, indicating that only the transferred healthy mitochondria were of benefit to the retina, besides the paracrine 0 effects. This is consistent with previous study using Transwell units that the crosstalk between paracrine action and mitochondrial transfer is an interaction of two independent processes with consequent MSC-mediated cell protection (Vallabhaneni et al., 2012) .
In 
Methods
In vitro cell culture and labeling
Intravitreal Injection
To determine whether iPSC-MSCs could exert their neuroprotective effect in Ndufs4-/mice via intercellular mitochondrial transfer, iPSC-MSC treatment was performed via intravitreal injection. iPSC-MSCs or PBS and iPSC-MSCs(R) were injected into the vitreous body of mice at age 3 weeks. A cell suspension containing 1 × 10 4 iPSC-MSCs/ iPSC-MSCs(R) in 0.5 μ L PBS was slowly injected into the vitreous cavity.
The same volume of PBS was injected as the placebo control group. At 96 hrs, 1 week and 4 weeks after injection, mice were sacrificed for examination. Eyes with either cataract or vitreous hemorrhage after the injection were excluded from the study.
Electroretinography (ERG)
To evaluate the visual function of WT and KO Ndufs4 mice, scotopic flash electroretinography (ERG) was performed. To demonstrate the effect of iPSC-MSC treatment, ERG was performed 1 and 4 weeks after injection. After overnight dark adaption, mice were anesthetized by 1:1 mixture of ketamine and xylazine, pupils were dilated using mydriasis. Both eyes were anesthetized topically with 0.5% proparacaine (Alcon, US), ring shape gold electrodes were placed closely contact the cornea of both eyes and a ground electrode was placed subcutaneously by the tail. After 10 min adaption, eyes were exposed to a series of increasing intensity light flashes. 
Assessment of mitochondrial transfer and Müller Cell Activation
Mitochondrial transfer and Müller Cell Activation were detected via immunofluorescence on flat mounted retina. To observe mitochondrial transfer within the retina following iPSC-MSC injection, TUBB3/Brn3a was used to locate RGCs and anti-GFP/anti-hMito were used to label mitochondria from iPSC-MSCs 
Polymerase chain reaction (PCR)
Total DNA of the retina was extracted using a DNA kit (Qiagen, 74104 Sample concentrations (pg/ml) were determined from mean fluorescence intensities (median values) compared with five-parameter linear regression standard curves generated from standards provided by the manufacturer.
Statistical analysis
Statistical analysis was performed using Prism 5.04 Software (GraphPad Software for Windows, San Diego, CA, USA), and results are reported as mean ± S.D.
Comparisons between more than two groups were analyzed by one-way ANOVA test.
Comparisons between two groups were performed using Student's t-test. A p-value <0.05 was considered significant. 
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The Paper Explained
Problem
Retinal ganglion cell (RGC) degeneration is extremely difficult to repair and is often associated with mitochondrial dysfunction. Transplantation of mesenchymal stem cell (MSC) holds promise to protect RGC but beneficial mechanisms are largely unknown.
Results
Here, we report intravitreal transplantation of iPSC-MSCs could overcome the barrier of the inner limiting membrane of the retina, donate functional mitochondria to rescue RGCs from degeneration in mitochondrial Ndufs4 deficient mice, Importantly;
the beneficial effects of mitochondrial donation by MSCs were associated with management of mitochondrial damage-induced excessive inflammation and overall preservation of RGC functions (Figure 7) .
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Figure legends
